Search Results - "Scholler, N"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma by McIntosh, M.W., Drescher, C., Karlan, B., Scholler, N., Urban, N., Hellstrom, K.E., Hellstrom, I.

    Published in Gynecologic oncology (01-10-2004)
    “…The serum tumor marker CA 125 is elevated in most clinically advanced ovarian carcinomas. Because these elevations may precede clinical detection by a year or…”
    Get full text
    Journal Article
  2. 2

    CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8+ T Cells by Scholler, Nathalie, Hayden-Ledbetter, Martha, Hellstrom, Karl-Erik, Hellstrom, Ingegerd, Ledbetter, Jeffrey A

    Published in The Journal of immunology (1950) (15-03-2001)
    “…To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Bead-Based ELISA for Validation of Ovarian Cancer Early Detection Markers by SCHOLLER, Nathalie, CRAWFORD, Meghan, SATO, Alicia, DRESCHER, Charles W, O'BRIANT, Kathy C, KIVIAT, Nancy, ANDERSON, Garnet L, URBAN, Nicole

    Published in Clinical cancer research (01-04-2006)
    “…Purpose: Efforts to validate ovarian cancer early detection biomarkers with immunoassays are challenged by the limited specimen volumes available. We sought to…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Soluble Member(s) of the Mesothelin/Megakaryocyte Potentiating Factor Family are Detectable in Sera from Patients with Ovarian Carcinoma by Scholler, N, Fu, N, Yang, Y, Ye, Z, Goodman, G E, Hellström, K E, Hellström, I

    “…mAb OV569 was made by immunizing mice with ovarian carcinoma cells. It binds to cells from ovarian carcinomas and, to a lesser extent, to cells from certain…”
    Get full text
    Journal Article
  7. 7

    Method for generation of in vivo biotinylated recombinant antibodies by yeast mating by Scholler, Nathalie, Garvik, Barbara, Quarles, Travis, Jiang, Shaoyi, Urban, Nicole

    Published in Journal of immunological methods (20-12-2006)
    “…We describe here a novel method for generation of yeast-secreted, in vivo biotinylated recombinant antibodies, or biobodies. Biobodies are secreted by diploid…”
    Get full text
    Journal Article
  8. 8

    Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer ne ovas cularization by Nunez-Cruz, S, Gimotty, P A, Guerra, M W, Connolly, D C, Wu, Y-Q, DeAngelis, R A, Lambris, J, Coukos, G, Scholler, N

    Published in Neoplasia (New York, N.Y.) (01-11-2012)
    “…Complement activation plays a critical role in controlling inflammatory responses. To assess the role of complement during ovarian cancer progression, we…”
    Get full text
    Journal Article
  9. 9

    Cutting Edge: CD83 Regulates the Development of Cellular Immunity by Scholler, Nathalie, Hayden-Ledbetter, Martha, Dahlin, Amber, Hellstrom, Ingegerd, Hellstrom, Karl Erik, Ledbetter, Jeffrey A

    Published in The Journal of immunology (1950) (15-03-2002)
    “…We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8(+)…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Plasmid-based vaccines encoding rat neu and immune stimulatory molecules can elicit rat neu-specific immunity by Disis, Mary L, Scholler, Nathalie, Dahlin, Amber, Pullman, Janice, Knutson, Keith L, Hellström, Karl-Erik, Hellström, Ingegerd

    Published in Molecular cancer therapeutics (01-10-2003)
    “…DNA vaccines are ideally suited for immunizing against tumor antigens because constructs can be formulated that not only encode the tumor antigen but also…”
    Get full text
    Journal Article
  12. 12

    CD3-Mediated Activation of Tumor-Reactive Lymphocytes from Patients with Advanced Cancer by Hellström, Ingegerd, Ledbetter, Jeffrey A., Scholler, Nathalie, Yang, Yi, Ye, Zhengmao, Goodman, Gary, Pullman, Janice, Hayden-Ledbetter, Martha, Hellström, Karl Erik

    “…Lymphocytes from blood or tumors of patients with advanced cancer did not proliferate and produced very low levels of tumor necrosis factor and IFN-γ when…”
    Get full text
    Journal Article
  13. 13

    CD83 Regulates the Development of Cellular Immunity by Scholler, N, Hayden-Ledbetter, M, Dahlin, A, Hellstroem, I, Hellstroem, KE, Ledbetter, JA

    Published in The Journal of immunology (1950) (15-03-2002)
    “…We recently found that human CD83, a marker of mature dendritic cells, is an adhesion receptor that binds to resting monocytes and a subset of activated CD8…”
    Get full text
    Journal Article
  14. 14

    CD83 is an I-type lectin adhesion receptor that binds monocytes and a subset of activated CD8+ T cells [corrected] by Scholler, N, Hayden-Ledbetter, M, Hellström, K E, Hellström, I, Ledbetter, J A

    Published in The Journal of immunology (1950) (15-03-2001)
    “…To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region…”
    Get full text
    Journal Article
  15. 15

    CD83 Is a Sialic Acid-Binding Ig-Like Lectin (Siglec) Adhesion Receptor that Binds Monocytes and a Subset of Activated CD8 super(+) T Cells by Scholler, N, Hayden-Ledbetter, M, Hellstroem, K, Hellstroem, I, Ledbetter, JA

    Published in The Journal of immunology (1950) (15-03-2001)
    “…To help determine CD83 function, a cDNA encoding a soluble protein containing the CD83 extracellular domain was fused with a mutated human IgG1 constant region…”
    Get full text
    Journal Article
  16. 16